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Cancer is a serious concern at present. A large number of patients die each year
due to cancer illnesses in spite of several interventions available. Development of an
effective and side effects lacking anticancer therapy is the trending research direction
in healthcare pharmacy. Chemical entities present in plants proved to be very potential
in this regard. Bioactive phytochemicals are preferential as they pretend differentially on
cancer cells only, without altering normal cells. Carcinogenesis is a complex process
and includes multiple signaling events. Phytochemicals are pleiotropic in their function
and target these events in multiple manners; hence they are most suitable candidate
for anticancer drug development. Efforts are in progress to develop lead candidates
from phytochemicals those can block or retard the growth of cancer without any side
effect. Several phytochemicals manifest anticancer function in vitro and in vivo. This
article deals with these lead phytomolecules with their action mechanisms on nuclear
and cellular factors involved in carcinogenesis. Additionally, druggability parameters and
clinical development of anticancer phytomolecules have also been discussed.
Keywords: cancer, limitations of anticancer drugs, anticancer phytochemicals, druggability evaluation
INTRODUCTION
Cancer, a severe metabolic syndrome, is the leading cause of mortality and morbidity worldwide
and the number of cases are continuously rising (Sharma et al., 2014; American Cancer Society,
2016). This disease ranks second in death cases after cardiovascular disorders in the developed
nations (Mbaveng et al., 2011; Siegel et al., 2016). The cancer phenomenon is described by
uncontrolled proliferation and dedifferentiation of a normal cell. Cancer cells have some marked
features i.e., they tune out the signals of proliferation and differentiation, they are capable to sustain
proliferation, they overcome the apoptosis, and they have power of invasion and angiogenesis.
Sequential genetic alterations which produce genetic instabilities accumulate in the cell and a
normal cell transforms into a malignant cell. These alterations include mutations in DNA repair
genes, tumor suppressor genes, oncogenes and genes involve in cell growth & differentiation.
These modifications are not just abrupt transitions but may take several years. Both external
(e.g., radiations, smoking, pollution and infectious organisms) and internal factors (e.g., genetic
mutations, immune conditions, and hormones) can cause cancer. Various types of cancer forms
exist in human (Table 1); and the lung, breast and colorectal cancer being the most common
forms (Ferlay et al., 2010). Among these the lung cancer is reported the most in men and the
breast cancer in women (Horn et al., 2012). Several genes coordinate together for the growth &
differentiation of a normal cell. In the cancer, one or group of these genes get altered and express
aberrantly (Biswas et al., 2015). These genes can be targeted for the development of anticancer
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therapeutics. Modifications of epigenetic processes involved in
cell growth and differentiation also lead to the development
of a cancer. Therapeutic interventions which can reverse
these epigenetic alterations may also be a promising option
in anticancer drug discovery (Schnekenburger et al., 2014).
Azacitidine, decitbine, vorinostat, and romidespin are exemplary
epigenetic anticancer drugs in this regard.
DRUGS FOR CANCER TREATMENT
Cancer treatment involves surgery of tumor, radiotherapy,
and chemotherapy. Treatment method depends upon the
stage and location of tumor. Chemotherapy involves cytotoxic
and cytostatic drugs and proved to be very efficient when
used in combination with other therapies. Authoritative
chemotherapeutics include alkylating agents, topoisomerase
inhibitors, tubulin acting agents and antimetabolites. Alkylating
agents bind covalently with DNA, crosslink them and
generate strand breaks. Carboplatin, cisplatin, oxaliplatin,
cyclophosphamide, and melphalan are exemplary alkylating
agents which work by causing such DNA damage. Doxorubicin
and irinotecan are topoisomerase inhibitors and hinder
DNA replication. Tubulin acting agents interrupt mitotic
spindles and arrest mitosis. Paclitaxel, docetaxel, vinblastine
and vincristine act on tubulins. Paclitaxel (C47H51NO14) has
been proved an effective anticancer drug against most of the
cancer types. It was isolated in 1967 from the endophytic
fungi found in Taxus brevifolia bark (Carsuso et al., 2000).
Paclitaxel targets tubulin and suppress microtubules detachment
from the centrosomes. It induces multipolar divisions by
forming abnormal spindles which bear additional spindle
poles. This results in unnatural chromosome segregation and
abnormal aneuploid daughter cells which go in apoptosis
direction (Weaver, 2014). Antimetabolites stop nucleic acid
synthesis and examples are methotrexate and 5-fluorouracil.
Some other drugs with specific targets are also approved
for the treatment of cancer. Bevacizumab inhibits vascular
endothelial growth factor receptor and has been used to
treat metastatic cancers (Van Meter et al., 2010). Rituximab
targets CD20 in lymphoma, imatinib targets Bcr/Abl, gefitinib
acts on epithelial growth factor receptor and bortezomib is
approved as proteosome inhibitor (Murawski and Pfreundschuh,
2010).
LIMITATIONS OF AVAILABLE ANTICANCER
DRUGS
Existing anticancer drugs target rapidly dividing cells. Several
cells in our body proliferate quickly under normal circumstances,
viz. bone marrow cells, digestive tract cells and hair follicle cells.
So these normal cells are also affected by the above mentioned
drugs and serious side effects emerge. These side effects
include myelosuppression (decreased production of blood
cells), mucositis (inflammation of digestive tract lining), hair
loss, cardiotoxicity, neurotoxicity and immunosuppression.
Additionally, rapid elimination and widespread distribution
TABLE 1 | Some epidemiological forms of cancer.
Lung cancer Breast cancer Colorectal cancer
Lymphoma Melanoma Leukemia
Stomach cancer Brain tumor Prostate cancer
Cervical cancer Ovary cancer Kidney cancer
Liver cancer Oral cavity cancer Larynx cancer
Malignant ascites Skin cancer Uterus cancer
Pancreas cancer Urinary bladder cancer Thyroid cancer
Fibrosarcoma Lymphosarcoma
of the introduced drug to the non-targeted organs by body
system requires large dose of the drug which increases above
mentioned side effects and also not economic. Another
limitation is the resistance of cancer cells to the available drugs.
Cancer cells undergo mutations and become resistant to the
introduced drugs. Therefore, given the reality of unsatisfactory
chemotherapy, innovations in treating cancer with fewer side
effects are the trending research direction. An ideal anticancer
drug will specifically be cytotoxic toward the cancer cells only
and based on the research findings, phytochemicals & derivatives
present in plants are promising option for the improved and
less toxic cancer therapy. Bioactive phytochemicals possess
diverse therapeutic functions (e.g., analgesic, anti-inflammatory,
antitumor and many more). These phytomedicines cover
an important portion of our current pharmaceutics
(Table 2).
PLANTS AS INDISPENSABLE SOURCES
FOR ANTICANCER PHYTOCHEMICALS
Plants and their formulations are in medicinal uses since ancient
times. Various herbal preparations with different philosophies
and cultural origins are used by folk medicine practitioners to
heal kinds of diseases. Ayurveda, the ancient Vedic literature
of India, is the science of good health and well-being (Behere
et al., 2013). It is the collection of traditional and cultural
philosophies to cure the diseases. Modern drug development
program based on ayurveda concepts has gained wide acceptance
in present healthcare system. Plant derived natural products are
nontoxic to normal cells and also better tolerated hence they gain
attention of modern drug discovery. Estimated figures reveal that
plant kingdom comprises at least 250,000 species and only 10
percent have been investigated for pharmacological applications.
Phytochemicals and their derived metabolites present in root,
leaf, flower, stem and bark perform several pharmacological
functions in human systems. Alkaloids, flavonoids, phenolics,
tannins, glycosides, gums, resins and oils are such responsible
elements (Singh et al., 2013). These elements or their altered
forms have shown significant antitumor potential. Vinblastine,
vincristine, taxol, elliptinium, etoposide, colchicinamide,
10-hydroxycamptothecin, curcumol, gossypol, ipomeanol,
lycobetaine, tetrandrine, homoharringtonine, monocrotaline,
curdione, and indirubin are remarkable phytomolecules in this
regard (Figure 1).
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TABLE 2 | Medicinal products derived from plants.
Drug Pharmacological function
Aspirin Analgesic, anti-inflammatory
Atropine Pupil dilation
Bromelain Anti-inflammatory
Colchicine Anticancer
Digitoxin Cardiotonic
Ginkgolides Brain disorders
Harpogoside Rheumatism
Hyoscyamine Anti-cholinergic
Morphine Analgesic
Podophyllotoxin Anticancer
Quinine Antimalarial
Reserpine Anti-hypertensive
Salicin Analgesic
Silymarin Antihepatotoxic
Sitosterol Prostate hyperplasia
Taxol Anticancer
Vincristine and vinblastine Anticancer
Tubocurarine Mascular relaxation
ANTICANCER FUNCTIONS OF
PHYTOCHEMICALS ON ANIMAL AND
CELLULAR MODELS
Several plant species have been discovered to suppress the
progression and development of tumors in cancer patients
(Umadevi et al., 2013) and many phytochemicals have
been identified as active constituents in these plant species
(Table 3). Phytochemicals exert antitumor effects via distinct
mechanisms. They selectively kill rapidly dividing cells, target
abnormally expressed molecular factors, remove oxidative
stress, modulate cell growth factors, inhibit angiogenesis of
cancerous tissue and induce apoptosis. For example some
polyphenols (e.g., resveratrol, gallocatechins), flavonoids (e.g.,
methoxy licoflavanone, alpinumisoflavone), and brassinosteroids
(e.g., homocatasterone and epibrassinolide) exert anticancer
effects through apoptosis induction (Heo et al., 2014; Wen
et al., 2014). Curcumin, thymol, rosmarinic acid, β-carotene,
quercetin, rutin, allicin, gingerol, epigallocatechin gallate, and
coumarin perform anticancer functions through antioxidant
mechanisms.
Anticancer drug development involves in vitro cytotoxicity
on cancer cells, in vivo confirmation, and clinical trial
evaluation. Assessment of cytotoxicity toward cancer
cell lines is a trending strategy for the discovery of
anticancer agents. Cell viability assessment of cancer cells
is a high throughput screening method through which
numerous compounds can be screened in a short period
of time. Several such phytochemicals have been discovered
from plants and dietary supplements (Table 4). Crude
phytochemical extracts also suppress the viability of cancer
cells (Table 5).
MOLECULAR TARGETS AND
MECHANISMS OF ACTION OF
ANTICANCER PHYTOCHEMICALS
The exact mechanism by which phytochemicals perform
anticancer functions is still a topic of research. They exert
wide and complex range of actions on nuclear and cytosolic
factors of a cancer cell. They can directly absorb the reactive
oxygen species (ROS) or promote activities of antioxidant
enzymes (e.g., superoxide dismutase, glutathione and catalase)
in a transformed cell. A phytomolecule can suppress malignant
transformation of an initiated pre-neoplastic cell or it can
block the metabolic conversion of the pro-carcinogen. Also,
they can modulate cellular and signaling events involved in
growth, invasion and metastasis of cancer cell. Ellagic acid of
pomegranate induces apoptosis in prostate and breast cancer
cells, and inhibits metastasis processes of various cancer types.
Epigallocatechin gallate (EGCG) suppresses the activity of
ornithine decarboxylase, the enzyme which signals the cell
to proliferate faster and bypass apoptosis. Luteolin obstructs
epithelial mesenchymal transition. Flavanones, isoflavones and
lignans prevent binding of the estrogen to the cancer cells
and reduce their proliferation. Reduction of inflammation
processes through suppression of nuclear factor- kappa B
(NF-κB) family transcription factors is an additional mechanism.
Curcumin, bilberries anthocyanins, EGCG, caffeic acid and
derivatives and quercetin act via NF-κB signaling. Besides these
mechanisms, anticancer phytomolecules targets several other
signaling molecules/ pathways also to reduce the growth and
metastasis of cancer cells.
Apigenin, the flavone found in parsley, celery, and chamomile
targets leptin/leptin receptor pathway and induces apoptosis
in lung adenocarcinoma cells. It induces caspase dependent
extrinsic apoptosis in human epidermal growth factor receptor
2 (HER-2) over expressing BT-474 breast cancer cells through
inhibition of signal transducer and activator of transcription 3
(STAT3) signaling (Seo et al., 2015). Curcumin, the polyphenol
of Curcuma longa slows down the growth of human glioblastoma
cells bymodulating several molecular components. It upregulates
the expressions of p21, p16, p53, early growth response protein
1 (Egr-1), extracellular signal regulated kinase (Erk), c-Jun-
N-terminal kinase (JNK), ElK-1 (member of ETS oncogenic
family), Bcl-2 associated X protein (Bax) and Caspase- 3, 8, 9
proteins; and downregulates the levels of B cell lymphoma 2
(Bcl-2), mechanistic target of rapamycin (mTOR), p65, B cell
lymphoma extra-large protein (Bcl-xL), protein kinase B (Akt),
epidermal growth factor receptor (EGFR), NF-κB, cell division
cycle protein 2 (cdc-2), retinoblastoma protein (pRB), cellular
myelocytomatosis oncogenes (c-myc) and cyclin D1 proteins
(Vallianou et al., 2015).
Crocetin, the carotenoid present in Crocus sativus and
Gardenia jasminoides act on GATA binding protein 4 and
MEK-ERK1/2 pathway and protect against cardiac hypertrophy
(Cai et al., 2009). Cyanidin glycosides from red berries
execute antioxidant and anticancer functions through various
mechanisms. In colon cancer cells, they suppress the expressions
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FIGURE 1 | Chemical structures of some anticancer phytochemicals.
of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2
(COX-2) genes and inhibit mitogen induced metabolic pathways
(Serra et al., 2013). In human vulva cells, they target EGFR
and in breast cancer cells they block the ErbB2/cSrc/FAK
pathway and prevent their metastasis (Xu et al., 2010). EGCG,
the catechin polyphenol of tea exert anticancer effects through
multiple mechanisms. It blocks NF-κB activation, Bcl-2 and
COX-2 expression in prostate carcinoma cells and induces
apoptosis. In bladder and lung carcinoma cells, it inhibits matrix
metallopeptidase-9 (MMP-9) expression (Singh et al., 2011). In
head & neck carcinoma cells it suppresses the production of
vascular endothelial growth factor (VEGF). In fibrosarcoma cells
it prevents the Erk phosphorylation and activity of MMP-2 & 9.
And, in gastric carcinoma cells it suppresses the Erk, JNK, and
MMP-9 expressions (Luthra and Lal, 2016).
Fisetin and hesperetin cause cell cycle arrest in human acute
promyelocytic leukemia HL-60 cells by altering several signaling
networks, viz. mitogen activated protein kinases (MAPK), NF-
κB, JAK/STAT, PI3K/Akt, Wnt, and mTOR pathways (Adan
and Baran, 2015). Genistein, the isoflavone of soybean exerts
its anticancer effects via inhibition of NF-κB and Akt signaling
pathways (Li et al., 2012). Gingerol targets the Erk1/2/JNK/AP-
1 signaling and induces caspase-dependent apoptosis in colon
cancer cells (Radhakrishnan et al., 2014). Kaempferol acts on
proto-oncogene tyrosine protein kinase (Src), Erk1/2 and Akt
pathways in pancreatic cancer cells and retard their growth
& migration (Lee and Kim, 2016). Similarly, lycopene targets
PI3K/Akt pathway in pancreatic cancer cells. It prevents gastric
carcinogenesis by inhibiting Erk and Bcl-2 signaling (Kim and
Kim, 2015). It activates antioxidant enzymes (e.g., GST, GSH, and
GPx) in the cancer cells and removes oxidative damage produced
by the carcinogen. Rosmarinic acid reduces COX-2 activity and
Erk phosphorylation in colon cancer cells (Hossan et al., 2014). In
breast cancer cells, rosmarinic acid reduces the activity of DNA
methyl transferase and interfere RANKL/RANK/OPG networks.
Also, it targets PKA/CREB/MITF pathway and NF-κB activation
in melanoma and leukemia U938 cells respectively (Hossan et al.,
2014).
Calcitriol inhibits prostaglandins, COX-2, NF-κB, and VEGF
signaling and prevents angiogenesis of cancer cells (Diaz et al.,
2015). Tocotrienols and γ-tocopherol hinder PI3K/Akt and
Erk/MAPK pathways (Sylvester and Ayoub, 2013). Colchicine
upregulates dual specificity phosphatase 1 (DUSP1) gene in
gastric carcinogenesis (Lin et al., 2016). It also prevents the
growth of hepatocellular carcinoma cells through upregulation
of A-kinase anchoring protein 12 (AKAP12) and transforming
growth factor beta-2 (TGF-β2) proteins (Kuo et al., 2015).
Podophyllotoxin blocks the growth of MCF-7 breast cancer cells
by altering checkpoint kinase 2 (Chk-2) signaling pathway (Zilla
et al., 2014). Podophyllotoxin also promotes apoptosis in non-
small cell lung carcinoma cells through ER stress, autophagy and
cell cycle arrest (Choi et al., 2015). Vinblastine and taxol target
activator protein 1 (AP-1) signaling pathways (Flamant et al.,
2010). Resveratrol arrest carcinogenesis by multiple mechanisms,
viz. upregulation of p53 and BAX proteins and downregulation of
NF-κB, AP-1, hypoxia induced factor 1α (HIF-1α), MMPs, Bcl-2,
cytokines, cyclins, cyclin dependent kinases (CDKs) and COX-2
proteins (Varoni et al., 2016).
These phytomolecules act on epigenetic elements also. DNA
methylation, histone modifications and miRNAs expression
are important epigenetic processes which involve in cancer
initiation and progression. Phytomolecules reduce the activities
and expression of DNA methyl transferases (DNMTs), histone
deacetylases (HDACs) and histone methyl transferases (HMTs)
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TABLE 3 | Phytochemicals which demonstrated effective tumor killing in various cancer types.
Phytochemical(s) Cancer models suppressed References
Alexin B, Emodin (Aloe vera) Leukemia, stomach cancer, neuroectodermal tumors Elshamy et al., 2010
Allylmercaptocysteine, allicin (Allium sativum) Colon cancer, bladder carcinoma Ranjani and Ayya, 2012
Amooranin (Amoora rohituka) Breast, cervical, and pancreatic cancer Chan et al., 2011
Andrographolide (Andrographis paniculata) Cancers of breast, ovary, stomach, prostate, kidney,
nasopharynx malignant melanoma, leukemia
Geethangili et al., 2008
Ashwagandhanolide (Withania somnifera) Cancers of breast, stomach, colon, lung, and central
nervous system
Yadav et al., 2010
Bavachanin, corylfolinin, psoralen (Psoralea corylifolia) Cancers of lung, liver, osteosarcoma, malignant ascites,
fibrosarcoma, and leukemia
Wang et al., 2011
Berberine, Cannabisin-G (Berberis vulgaris) Cancers of breast, prostate, liver, and leukemia Elisa et al., 2015
Betulinic acid (Betula utilis) Melanomas Król et al., 2015
Boswellic acid (Boswellia serrata) Prostate cancer Garg and Deep, 2015
Costunolide, Cynaropicrine, Mokkolactone, (Saussurea lappa) Intestinal cancer, malignant lymphoma, and leukemia Lin et al., 2015
Curcumin (Curcuma longa) Cancers of breast, lung, esophagus, liver, colon, prostate,
skin and stomach
Perrone et al., 2015
Daidzein and genistein (Glycine max) Cancers of breast, uterus, cervix, lung, stomach, colon,
pancreas, liver, kidney, urinary bladder, prostate, testis, oral
cavity, larynx, and thyroid
Li et al., 2012
Damnacanthal (Morinda citrifolia) Lung cancer, sarcomas Aziz et al., 2014
β-Dimethyl acryl shikonin, arnebin (Arnebia nobilis) Rat walker carcinosarcoma Thangapazham et al., 2016
Emblicanin A & B (Emblica officinalis) Cancers of breast, uterus, pancreas, stomach, liver, and
malignant ascites
Dasaroju and Gottumukkala, 2014
Eugenol, orientin, vicenin (Ocimum sanctum) Cancers of breast, liver, and fibrosarcoma Preethi and Padma, 2016
Galangin, pinocembrine, acetoxy chavicol acetate (Alpinia
galangal)
Cancers of lung, breast, digestive systems, prostate, and
leukemia
Sulaiman, 2016
Gingerol (Zingiber officinale) Cancers of ovary, cervix, colon, rectum, liver, urinary
bladder, oral cavity, neuroblastoma, and leukemia
Rastogi et al., 2015
Ginkgetin, ginkgolide A & B (Ginkgo biloba) Glioblastoma multiforme, hepatocarcinoma, ovary, prostate,
colon, and liver
Xiong et al., 2016
Glycyrrhizin (Glycyrrhiza glabra) Lung cancer, fibrosarcomas Huang et al., 2014
Gossypol (Gossypium hirsutum) Cancers of breast, esophagus, stomach, liver, colon,
pancreas, adrenal gland, prostate, urinary bladder,
malignant lymphoma & myeloma, brain tumor, and leukemia
Zhan et al., 2009
Kaempferol galactoside (Bauhinia variegata) Cancers of breast, lung, liver, oral cavity, larynx, and
malignant ascites
Tu et al., 2016
Licochalcone A, Licoagrochalcone (Glycyrrhiza glabra) Cancers of prostate, breast, lung, stomach, colon, liver,
kidney, and leukemia
Zhang et al., 2016
Lupeol (Aegle marmelos) Breast cancer, lymphoma, melanoma, and leukemia Wal et al., 2015
Nimbolide (Azadirachta indica) Colon cancer, lymphoma, melanoma, leukemia, and
prostate cancer
Wang et al., 2016
Panaxadiol, panaxatriol (Panax ginseng) Cancers of breast, ovary, lung, prostate, colon, renal cell
carcinoma, leukemia, malignant lymphoma, and melanoma
Du et al., 2013
Plumbagin (Plumbago zeylanica) Cancers of breast, liver, fibrosarcoma, leukemia, and
malignant ascites
Yan et al., 2015
Podophyllin & podophyllotoxin (Podophyllum hexandrum) Cancers of breast, ovary, lung, liver, urinary bladder, testis,
brain, neuroblastoma, and Hodgkin’s disease
Liu et al., 2015
Psoralidin (Psoralea corylifolia) Stomach and prostate cancer Pahari et al., 2016
Sesquiterpenes and diterpenes (Tinospora cordifolia) Lung, cervix, throat, and malignant ascites Gach et al., 2015
6-Shogaol (Zingiber officinale) Ovary cancer Ghasemzadeh et al., 2015
Skimmianine (Aegle marmelos) Liver tumors Mukhija et al., 2015
Solamargine, solasonine (Solanum nigrum) Cancers of breast, liver, lung, and skin Al Sinani et al., 2016
Thymoquinone (Nigella sativa) Colon, breast, prostate, pancreas, uterus, malignant
lymphoma, ascites, melanoma, and leukemia
Fakhoury et al., 2016
(Continued)
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TABLE 3 | Continued
Phytochemical(s) Cancer models suppressed References
Ursolic acid and oleanolic acid (Prunella vulgaris) Cancers of breast, cervix, lung, oral cavity, esophagus,
stomach, colon, thyroid, malignant lymphoma, intracranial
tumors, and leukemia
Wozniak et al., 2015
Ursolic acid (Oldenlandia diffusa) Cancers lung, ovary, uterus, stomach, liver, colon, rectum,
brain, lymphosarcoma, and leukemia (Al Sinani et al., 2016)
Wozniak et al., 2015
Vinblastine, vincristine (Catharantus roseus) Cancers of breast, ovary, cervix, lung, colon, rectum, testis,
neuroblastoma, leukemia, rhabdomyosarcoma, malignant
lymphoma, and hodgkin’s disease
Keglevich et al., 2012
Viscumin, digallic acid (Viscum album) Cancers of breast, cervix, ovary lung, stomach, colon,
rectum, kidney, urinary bladder, testis, fibrosarcoma,
melanoma
Bhouri et al., 2012
Withaferin A, D (Withania somnifera) Cancers of breast, cervix, prostate, colon, nasopharynx,
larynx, and malignant melanoma
Lee and Choi, 2016
TABLE 4 | Phytochemicals which are cytotoxic against cancer cell lines.
Phytochemical(s) Cell line References
Actein (Actaea racemosa) HepG2 (liver cancer), MCF7 (breast cancer) Einbonda et al., 2009
β-Aescin (Aesculus hippocastanum) HT29 (colorectal adenocarcinoma) Zhang et al., 2010
Allylmercaptocysteine, allicin (Allium sativum) HeLa (cervix cancer), L5178Y (lymphoma), MCF7 Karmakar et al., 2011
Amooranin (Amoora rohituka) MCF7, CEM (lymphocytic leukemia) Chan et al., 2011
Asiatic acid (Centella asiatica) EAC (ehrlich ascites carcinoma), DLA ( dalton’s lymphoma
ascites), SK-MEL-2 (melanoma), U-87-MG (glioblastoma),
B16F1 (melanoma), MDA-MB-231 (breast adenocarcinoma)
Heidari et al., 2012
Baicalein (Scutellaria baicalensis) LXFL-529L (lung cancer) Zhou et al., 2008
Carnosic acid, rosmarinic acid (Rosmarinus officinalis) A549 (lung cancer), SMMC7721 (liver cancer), A2780 (ovary
cancer)
Tai et al., 2012
β-Caryophyllene, α-zingiberene (Peristrophe bicalyculata) MCF7, MDA-MB-468 Ogunwande et al., 2010
Cinnamaldehyde (Cinnamomum zeylanicum) HeLa, HCT116 (colorectal carcinoma), HT29 Koppikar et al., 2010
Clausenalansamide A and B (Clausena lansium) SGC-7901 (gastric cancer), HepG2, A549 Maneerat et al., 2011
Corydine, salutaridine (Croton macrobotrys) NCI-H460 (lung cancer), K5662 (leukemia) Motta et al., 2011
Conyzapyranone A and B (Conyza Canadensis) HeLa, A431 (epidermoid carcinoma), MCF7 Csupor-Loffler et al.,
2011
Costunolide, tulipinolide, liriodenine, germacranolide (Liriodendron
tulipifera)
KB (oral cancer), HT29 Wang et al., 2012
Crocin, picrocrocin, crocetin, and safranal (Crocus sativus) S-180 (sarcoma), EAC, DLA, Tca8113 (oral cancer), and
HCT116
Bakshi et al., 2009
Dioscin (Dioscorea colletti) HepG2, SGC-7901 Hu et al., 2011
Epicatechin, procyanidin B2, B4 (Litchi cinensis) MCF7 Bhoopat et al., 2011
Gallic acid (Leea indica) EAC Raihan et al., 2012
Harringtonines (Cephalotaxus harringtonia) P388 (blood cancer), L-1210 (blood cancer) Jin et al., 2010
Hydroxycinnamoyl ursolic acid (Vaccinium macrocarpon) MCF7, ME180 (cervical cancer), and PC3 (prostate cancer) Kondo et al., 2011
Leachianone A (Radix sophorae) HepG2 Long et al., 2009
Lectin (Hibiscus mutabilis) HepG2, MCF7 Lam and Ng, 2009
Naphthoquinones (Tabebuia avellanedae) EAC, DU145 (prostate cancer) Yamashita et al., 2009
Niazinine A (Moringa oliefera) AML (blood cancer), HepG2 Khalafalla et al., 2011
Pectolinarin (Cirsium japonicum) S180, H22 (liver cancer) Yin et al., 2008
Piperine, piperidine (Piper nigrum) B16F10 (melanoma) Liu et al., 2010
Platycodin D (Platycodon grandiflorum) A549, HT29 Shin et al., 2009
Plumbagin (Plumbago zeylanica) PC3, A549, NB4 (blood cancer), A375 (skin cancer), SGC7901 Checker et al., 2010
Pyrogallol (Emblica officinalis) L929 Baliga and Dsouza, 2011
Tylophorine (Tylophora indica) A549, DU145, ZR751 (breast cancer) Kaur et al., 2011
Withaferin A (Withania somnifera) MCF7, MDA-MB-231 Hahm et al., 2011
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TABLE 5 | Plants whose phytochemical preparation is cytotoxic toward cancer cell lines.
Plant Cancer cell line(s) GI50 (µg/ml)
# References
Abelia triflora (leaf) A549 1000 Al-Taweel et al., 2015;
Rafshanjani et al., 2015
Abutilon indicum (leaf) A549 85.2 Kaladhar et al., 2014
Amphipterygium adstringens
(bark)
OVCAR3 (ovary adenocarcinoma) Garcia et al., 2015
Annona crassiflora and A.
coriacea (leaf and seed)
UA251 (glioma), UACC62 (lymphoid melanoma), MCF7,
NCIH460 (lung cancer), 786-0 (renal carcinoma), HT29,
NCIADR-RES (ovary cancer), OVCAR, K562 (myeloid leukemia)
≈8.9 Formagio et al., 2015
Argemone gracilenta M12.C3F6 (B-cell lymphoma)
RAW264.7 (leukemia)
HeLa
46.2
64.45
78.87
Leyva-Peralta et al., 2015
Camellia sinensis (black tea) MCF-7 0.0125 Konariková et al., 2015
Catharanthus roseus Emblica
officinalis (fruit)
HCT116 46.21
35.21
Bandopadhyaya et al., 2015
Centaurea kilaea MCF7
HeLa
PC3
60.7
53.07
73.92
Selvarani et al., 2015; Sen
et al., 2015
Chamaecyparis obtuse (leaf) HCT116 1.25 Kim et al., 2015
Chresta sphaerocephala (leaf
and stem)
OVCAR3
786-0
U251
50.4
72.3
77.6
Da Costa et al., 2015
Cichorium intybus MCF7 429 Gospodinova and Krasteva,
2015
Croton sphaerogynus (leaf) U251, MCF7, NCIH460 – dos Santos et al., 2015
Curcuma longa (rhizome) A549 207.3 Shah et al., 2015
Elaeocarpus serratus (leaf) MCF7 227 Sneha et al., 2015
Fraxinus micrantha MCF7 18.95 Kumar and Kashyap, 2015
Harpophyllum caffrum (leaf) HCT116
A549
MCF7
HepG2
29
28.8
21
29
El-Hallouty et al., 2015
Holarrhena floribunda (leaf) MCF7
HT29
HeLa
126.7
159.4
106.7
Badmus et al., 2015
Ipomoea quamoclit (leaf) CNE1 (nasopharynx carcinoma)
HT29
MCF7
HeLa
18
18
31
33
Ho et al., 2015
Ipomoea pestigridis (leaf) HepG2 155.2 Begum et al., 2015;
Kabbashi et al., 2015
Justicia tranquibariensis (roots) HeLa >200 Jiju, 2015; Nair et al., 2015
(Continued)
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TABLE 5 | Continued
Plant Cancer cell line(s) GI50
(µg/ml)#
References
Nardostachys jatamansi (roots
and rhizome)
MCF7
MDA-MB-231
58.01
23.83
Chaudhary et al., 2015
Piper cubeba (seed) MCF7
MDA-MB-468
22.31
21.84
Graidist et al., 2015
Piper pellucidum (leaf) HeLa 2.85 Wahyu et al., 2013
Premna odorata (bark) HCT116
MCF7
A549
AA8
8.58
8.42
11.42
18.09
Tantengco and Jacinto,
2015
Psidium guajava (leaf) EAC
HeLa
MDA-MB-231
MG-263
25
49.5
6.19
6.19
Shakeera and Sujatha, 2015
Robinia pseudoacacia C6 (glioma), MCF, T47D (breast cancer), A549 - Bhat et al., 2015
Rubus fairholmianus (root) Caco2 20 George et al., 2015
Sansevieria liberica (root) HeLa
HCT116
THP1 (leukemia)
23
22
18
Akindele et al., 2015
Sideritis syriaca (leaf) MCF7 100 Yumrutas et al., 2015
Solanum nigrum HeLa SiHa (cervix carcinoma) C33A (cervix carcinoma) 250
87.5
100
Paul et al., 2015
Theobroma cacao (leaf) MCF7 41.4 Baharum et al., 2014
Trapa acornis (shell) SKBR3 (breast cancer)
MDA-MB-435
56.07
31.60
Pradhan and Tripathy, 2014
Tridax procumbens A549, HepG2 - Priya and Srinivasa, 2015
Triumfetta welwitschii Jurkat T cells (T-cell leukemia) – Batanai and Stanley, 2015
Vernonia amygdalina (leaf) HL60
SMMC7721
A549
MCF7
SW480 (colorectal adenocarcinoma)
5.58
8.74
10.97
9.51
8.84
Iweala et al., 2015
Vinca major (aerial parts) HEp-2 (HeLa derived) 228 Singh et al., 2014
#Concentration of plant preparation at which 50% growth inhibition of cells found.
and increase promoter demethylation in various cancer models
(Thakur et al., 2014).
PROCESS DEVELOPMENT FOR
PURIFICATION OF ANTICANCER
PHYTOCHEMICALS
Therapeutic efficacy of any medicinal plant depends upon the
quality and quantity of the active phyto-constituent(s), which
vary with latitude, altitude, climate and season. Different parts
of a plant may possess different level of pharmacological activity.
Additive or synergistic effects of bioactive phyto-constituents
might be responsible for the concerned pharmacological function
rather than the purified one. These bioactive phyto-constituents
can be developed in antitumor therapeutic entities but they
demand intense effort. Several approaches can be used to
purify these pharmacologically active phytochemicals. These
include isolation and assay, combinatorial chemistry and
bioassay-guided fractionation. Bioassay guided fractionation
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FIGURE 2 | Development of the bioactive phytomolecule(s) into an
anticancer product.
involves the separation of bioactive phytochemicals from a
mixture of compounds using various analytic techniques based
on biological activity testing. The process begins with the testing
of natural extract with the confirmed bioactivity. The active
extract is fractionated on suitable matrices, eluted fractions
are tested for bioactivity and active fractions are examined
by various analytic techniques, viz. thin layer chromatography
(TLC), HPLC, FTIR, andMass spectroscopy (MS). This approach
can also be used to purify antimicrobial, antilipolytic and
antioxidant compounds (Figure 2). Solvents should be used in
an increasing polarity order. Silica, Sephadex, Superdex, or any
other suitable matrix can be used for fractionation. Vanilline-
sulfuric acid can be used as dyeing reagent for the detection
natural compounds. The procedures may be modified but purity
and quantity of the bioactive molecule must be high as much
as possible and this can be achieved by using good quality of
solvents, experimental careful handling and efficiency of the
procedure. After purification, molecule(s) must be examined
in vivo for the anticancer effects. If a promising tumor killing
is achieved by the molecule then other parameters i.e., safety
and adverse effects, dose concentration, pharmacokinetics, drug
interactions etc. must be explored for the drug molecule.
DRUGGABILITY EVALUATION OF
NATURAL PRODUCTS
Bioactive functional leads of natural origins can be used
as original or must be converted into the druggable forms.
Outrageous cost and reduced number of new drug approvals
are serious challenges to the new drug discovery. The major
task in plant-based drug discovery is the selection of right
candidate species of pharmacological activity. This identification
can be achieved using several approaches, viz. random selection,
ethnopharmacology, codified systems of medicine, ayurvedic
classical texts or zoopharmacognosy. Analysis of ayurvedic
attributes of ancient healing formulations for the initial selection
and bioactivity guided fractionation of the identified plant is a
strategy of worth with greater success rate and reduced cost,
time, and toxicity parameters. The Bhavprakash is an important
ayurvedic text for the cancer prevention. The botanic candidate
can be selected on the basis of ethnomedicine uses also. These
plant species can be safer than the species with no history
of human use. Another challenge with plant based medicinal
products is their poor bioavailability due to excessive degradation
by drug metabolic enzymes. The chemical entities of plants
have greater steric complexity, greater number of chiral centers,
greater number of hydrogen bond donors and acceptors, diverse
in aromaticity and higher molecular mass and rigidity which
pose strings of challenges in their development into a clinical
product.
Therapeutic phytomolecules and dietary supplements of
natural origins are governed by Food and Drug Administration
(FDA, USA) and Dietary Supplement Health and Education Act
1994 respectively for their pharmacological effects and safety
issues. Despite having desired bioactivity and ADMET profile
(absorption, distribution, metabolism, excretion, and toxicity),
most of the chemical entities of natural origin do not fulfill
Lipinski’s “rule of five” the drug likeness criteria according to
which, a candidate should have less than 500 Da molecular
weight, less than 5 hydrogen bond donors, less than 10 hydrogen
bond acceptors and less than 5 partition coefficient (logP) for
being work as a drug molecule. These rules are aimed to
achieve highest bioavailability. Nonetheless some breakthrough
natural products for e.g., paclitaxel would have never become
a drug based on these Lipinski’s conventions. So there is an
essential need to develop suitable druggability standards for
the compounds/formulations of natural origins. Various coating
materials, micelles, liposomes, phospholipid complexes and
nano-materials may be used to enhance the bioavailability of
phytomedicines.
CONCLUSION
The world is moving toward natural products due to their low
cost and reliability over side effects resulted from existing drugs.
Researchers are intensifying their efforts for the development
of phytopharmaceuticals against severe metabolic syndromes
including cancer. Bioactive phytochemicals/formulations are
potential leads for the development of safer anticancer drugs.
Several plants and their constitutive phytochemicals have been
screened for this purpose but only a very few have reached
up to the clinical level. Anticancer phytochemicals described
in this article must be further researched in clinical trials for
their effectiveness and toxicological documentation. They must
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be developed as druggable forms with sufficient bioavailability.
Moreover, we know that a traditional herbal preparation has
greater medicinal effect than the same phytochemical/molecule
taken in a pure form. So therapeutic intervention based upon
the combination of anticancer molecules may give potent and
effective therapeutic results.
India is the largest producer of medicinal plants and many
of the current health care products. Substantial scientific work
has been done on Indian plants and their products for the
treatment of frightful diseases. They must be explored for
anticancer potential. Furthermore, medicinal attributes put the
medicinal plants in high demand and draw the attention of
world in risking their biodiversity. Due to increasing demand
and deforestation, over exploitation of the medicinal plants
continues worldwide with time. Thus, some of the medicinal
plants may become extinct soon. Therefore, medicinal plants
need their conservation also. Germplasm preservation, viable
seed preservation and cryopreservation are promising strategies
for the same. In final words, this review can help healthcare
pharmacy to explore values of medicinal plants to treat
malignancies.
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